益杰立科

Biotech/Healthcare

EpiGenic Therapeutics is developing next-generation gene-editing therapies that regulate multiple diseases through epigenome editing. The company was founded by leading gene-editing scientists and experienced entrepreneurs.

Latest round: Series B (2025)